Sartorius Unveils Platform Aimed at Scaling Autologous Cell Therapy
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
False
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 16, 2026
2 min read
Vector DNA integration was identified near or within the GLI1 oncogene in tumors from two treated patients
November 11, 2026
2 min read
Replacing guidance from 2011, the FDA's updated framework emphasizes potency assurance throughout cell and gene therapy development and manufacturing
November 11, 2026
2 min read
The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network
November 3, 2026
2 min read
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
False
Affiliations:
Specialties:
Areas of Expertise: